Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Terminated 2Not yet recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Endocrine 3Genitourinary 1

Conditions

Adrenal Gland Neoplasms 2Urinary Bladder Neoplasms 1Pheochromocytoma 1Carcinoma, Renal Cell 1

Interventions

Everolimus 32Octreotide 15Cisplatin 14pasireotide 13Sunitinib 13Temozolomide 11pembrolizumab 10Etoposide 10Doxorubicin 10lanreotide 9Magnetic Resonance Spectroscopy 9Bevacizumab 9lutetium Lu 177 dotatate 8gallium Ga 68 dotatate 8Sorafenib 8Paclitaxel 83-Iodobenzylguanidine 8lenvatinib 7pazopanib 6Radiotherapy 6Positron Emission Tomography Computed Tomography 6Nivolumab 6surufatinib 5cabozantinib 5avelumab 5Thyrotropin Alfa 5Surgical Procedures, Operative 5Radiosurgery 5Mitotane 5Irinotecan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Adrenalectomy × Endocrine × Clear all
NCT06062082 2025-02-13

HEMODADRE

Central Hospital, Nancy, France

Completed
60 enrolled
Endocrine

Pheochromocytoma

NCT05888753 2023-06-22

Textbook Outcome in Adrenal Neoplasms

Hospital General Universitario de Alicante

Completed
105 enrolled
Endocrine

Adrenal Gland Neoplasms

NCT04570176 2022-02-16

Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System

The Affiliated Hospital of Qingdao University

Phase NA Completed
1 enrolled
EndocrineGenitourinary

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡